Cecilia Brown

Josie Montegaard, NP

Cancer Nursing Today nonprod

While there have been many advances in treatment for chronic lymphocytic leukemia (CLL), unmet needs and challenges remain, making future research critical.Josie Montegaard, NP, of the Dana-Farber Cancer Institute, spoke at JADPRO Live 2023, the Annual APSHO Meeting, about how she hopes to see the field move forward. She hopes researchers and clinicians can better understand how adverse event profiles differ among Bruton&rsquo;s tyrosine kinase (BTK) inhibitors. Regarding venetoclax-based regimens, she hopes the field can &ldquo;better optimize treatment duration&rdquo; with venetoclax for patients with CLL who have high-risk disease features, such as del(17p) or mutated TP53.Beyond these questions, it will also be important to understand how to sequence BTK inhibitors and venetoclax-based regimens in patients with CLL.&ldquo;Right now, I don&rsquo;t think there is a clear answer as to whether doing one drug first benefits the patient more than the other,&rdquo; Ms. Montegaard said. &ldquo;But as we get more data&mdash;particularly with giving patients BTK inhibitors after venetoclax because we have more data with giving venetoclax after BTK inhibitors&mdash;will that sort of change our approach and make us lean towards one or the other?&rdquo;

What Does the Future Hold for CLL Treatment?

Conferences

Josie Montegaard, NP, who spoke about CLL at JADPRO Live 2023, discusses BTK inhibitors, venetoclax, and how she hopes to see the field move forward.

About Us

Editorial Policy

Authors

Advertising

eNewsletters

Contact Us

Contribute

Calendar of Events

Career Center

Blood Cancers Today

GU Oncology Now

DocWire News

MashupMD

Urban Health Today

Breast Cancer

Colorectal Cancer

GI Cancer

GU Cancer

Gynecologic Cancer Awareness Month

Gyn-Onc

Blood Cancer Awareness Month

GVHD

Leukemia

Lymphoma

Myeloproliferative Neoplasms

Multiple Myeloma

Myelodysplastic Syndrome

Myelofibrosis

Sickle Cell

Hem/Onc

Professional Development

Patient Voice

Lung Cancer

Skin Cancer

Other Tumor Types

News

Treatment

More

Calendar

CARE Award

Best Practices

Expert Interviews

Subscribe